Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet Age-related Macular Degeneration

NCT00793923 is registered in ClinicalTrials.gov with Subhransu K. Ray, M.D., Ph.D. as lead sponsor.

NCT NCT00793923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00793923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet Age-related Macular Degeneration
Lead sponsor
Subhransu K. Ray, M.D., Ph.D.
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2008
Completion date
December 31, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exudative age-related macular degeneration